4.7 Review

Clinically established biodegradable long acting injectables: An industry perspective

Journal

ADVANCED DRUG DELIVERY REVIEWS
Volume 167, Issue -, Pages 19-46

Publisher

ELSEVIER
DOI: 10.1016/j.addr.2020.11.008

Keywords

Long acting injectables; Extended release; Drug delivery; PLGA microparticles; Microspheres; Implants; In situ forming implants; Drug crystals; Oil-based formulations; Drug crystal suspensions

Funding

  1. Next Generation Scientists Program(Novartis Pharma AG, Basel)

Ask authors/readers for more resources

Long acting injectable formulations have been developed to sustain the action of drugs in the body over desired periods of time. These delivery platforms have been utilized for both systemic and local drug delivery applications. This review gives an overview of long acting injectable systems that are currently in clinical use. These products are categorized in three different groups: biodegradable polymeric systems, including microparticles and implants; micro and nanocrystal suspensions and oil-based formulations. Furthermore, the applications of these drug delivery platforms for the management of various chronic diseases are summarized. Finally, this review addresses industrial challenges regarding the development of long acting injectable formulations. (C) 2020 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available